Monograph Details
|
|
Hematology
> Bleeding disorders
|
|
RHOPHYLAC |
| Manufacturer |
|
CSL Behring, LLC |
| Legal Classification |
|
Rx
|
| Generic Name |
|
Rho (D) immune globulin human 1500 IU (300micrograms)/2mL; syringe; for IV or IM inj; preservative- and latex-free; contains albumin (human); solvent/detergent treated. |
| Indications |
|
Raising platelet counts in Rho (D) positive non-splenectomized patients with chronic immune thrombocytopenic purpura (ITP). |
| Children |
|
Not recommended. |
| Adults |
|
See literature. 250 IU (50micrograms) per kg by IV only at rate of 2mL per 15–60 seconds. |
| Contraindications |
|
Rho (D) positive patients. IgA deficiency. |
| Precautions |
|
Monitor patients 20 minutes after administration. Pregnancy (Cat.C). |
| Interactions |
|
Do not give live vaccines within 3 months. |
| Adverse Reactions |
|
Local or infusion reactions, fever, chills, headache; see literature. |
| How Supplied |
|
Single-dose prefilled syringes—1, 10 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
